The HBV-ACLF nomogram to predict 90-day transplantation-free survival of patients with HBV-related ACLF was developed using the variables of age, WBC count, Hb, AST, TBil, INR, Cr, Na, AFP, HBV DNA, HE, and PreLD (Figure 2). Here, GSTM1 is linked to hereditary elliptocytosis.